Taurine Supplementation and Exercise on Irisin Levels in Obesity
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Taurine group and exercise and placebo group and exercise
Physical training with Deep Water Running
Sponsored by

About this trial
This is an interventional other trial for Obesity focused on measuring Obesity, Exercise, Irisin, Taurine, Energy Expenditure
Eligibility Criteria
Inclusion Criteria:
- This study included women with obesity grade I (BMI ≥30 - ≤35Kg/m²), sedentary, with no associated comorbidity, convenience sample.
Exclusion Criteria:
- Women classified as overweight, obesity grade II and grade III (morbid), who present comorbidities associated with obesity (pre-diabetes, diabetes, hypertension, dyslipidemia, cardiovascular diseases and diseases of bone metabolism); smokers; who use hormones, sports supplements and / or weight loss medications. Perform some type of nutritional monitoring followed by diet or weight loss guidelines and that have medical impediment to the practice of physical exercise.
Sites / Locations
- Gabriela Batitucci
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Taurine group and exercise
Placebo group and exercise
Arm Description
Intervention with taurine supplementation and physical training.
Intervention with placebo supplementation and physical training.
Outcomes
Primary Outcome Measures
Changes body weight
The body weight was measured by digital balance before and after the intervention
Changes body composition
The body composition was evaluated through deuterium oxide
Changes indirect calorimetry
With a gas analyzer (indirect calorimeter), we evaluated the metabolic rate and rest (REE) and oxidation of substrates (lipids and carbohydrates)
Changes in total cholesterol and lipid fractions
Collected in EDTA tubes, were centrifuged.
Changes in plasma taurine concentration
Collected in EDTA tubes, were centrifuged and the plasma taurine concentration was evaluated using HPLC (high performance liquid chromatography).
Changes in plasma irisin concentration
Collected in EDTA tubes, were centrifuged and the plasma irisin concentration was evaluated using Multiplex - Kit Human Myokine Magnetic Bead Panel.
Changes Food intake
Food registry of 3 days. The quantification of the daily intake of nutrients will still be made using sofware.
Changes in determination of lactate
Blood samples were collected by manual puncture of the earlobe in previously calibrated and heparinized capillary tubes, stored in eppendorf with sodium fluoride. Analyzed by electrochemical lactate analyser.
Changes Physical Performance
Maximum effort test, according to Wilder, Brennan e Schotte (1993).
Secondary Outcome Measures
Full Information
NCT ID
NCT04646512
First Posted
November 20, 2020
Last Updated
November 20, 2020
Sponsor
University of Sao Paulo
1. Study Identification
Unique Protocol Identification Number
NCT04646512
Brief Title
Taurine Supplementation and Exercise on Irisin Levels in Obesity
Official Title
Effects of Taurine Supplementation Associated With High Intensity Physical Training on Irisin Levels, Energy Expenditure and Body Composition of Obese Women
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
February 1, 2016 (Actual)
Primary Completion Date
May 1, 2016 (Actual)
Study Completion Date
August 1, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Irisin is a myocin secreted by skeletal muscle in stimulus to physical exercise and has been described as a possible therapeutic tool in the fight against obesity by triggering a cascade of signaling that triggers the expression of genes responsible for the increase in energy expenditure and browning of adipose tissue white cells by activating thermogenesis promoter mitochondrial proteins. Although the science is engaged in the search for evidences about the actions of the irisin, the physical exercise involved and the improvement in the levels of obesity, many mechanisms are still unknown. Since taurine by means of irisin-like pathways also increases energy expenditure, it is believed that taurine supplementation associated with high intensity aerobic physical exercise can optimize the effects of irisin, increasing energy expenditure and improving body composition in obesity.
Detailed Description
Introduction: Irisin is a myocin secreted by skeletal muscle when stimulated by physical exercise that promotes increased thermogenesis (browning effect). Similarly, taurine is also associated with modulations of energy metabolism with promising actions in the control of metabolic disorders. Thus, it is believed that chronic taurine supplementation associated with physical training can optimize irisin concentrations after exercise.
Objective: Evaluate the effects of taurine supplementation associated with interval aerobic training on plasma irisin concentrations, energy expenditure, body composition and physical fitness in obese women. Methods: Twenty-two women aged 25 to 45 years, sedentary, with grade I obesity (BMI ≥30-35 kg / m²) and without comorbidities will be recruited for the study. The subjects will be submited to a high intensity interval aerobic training for 8 weeks, being 3 times by week, for 50 minutes, associated to the supplementation with 3g of taurine or placebo.
Methods: Assessment of dietary intake, Resting Energy Expenditure (GER) by indirect calorimetry, body composition by deuterium oxide, anthropometric measurements, HPLC plasma analysis of taurine, multiplex irisin and physical fitness variables will be performed pre and post intervention. The results will be expressed as mean and standard deviation and the ANOVA test two way repeated measures mixed model will be applied, with post hoc Sidak, to verify differences and statistical interactions (p <0.05).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Obesity, Exercise, Irisin, Taurine, Energy Expenditure
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
double blind trial
Masking
ParticipantInvestigator
Masking Description
Intervention with taurine and / or placebo supplementation and physical training
Allocation
Randomized
Enrollment
31 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Taurine group and exercise
Arm Type
Active Comparator
Arm Description
Intervention with taurine supplementation and physical training.
Arm Title
Placebo group and exercise
Arm Type
Placebo Comparator
Arm Description
Intervention with placebo supplementation and physical training.
Intervention Type
Dietary Supplement
Intervention Name(s)
Taurine group and exercise and placebo group and exercise
Intervention Description
Both groups supplemented with taurine and / or placebo will perform physical training.
Intervention Type
Other
Intervention Name(s)
Physical training with Deep Water Running
Intervention Description
There will be a physical training for eight weeks.
Primary Outcome Measure Information:
Title
Changes body weight
Description
The body weight was measured by digital balance before and after the intervention
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Title
Changes body composition
Description
The body composition was evaluated through deuterium oxide
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Title
Changes indirect calorimetry
Description
With a gas analyzer (indirect calorimeter), we evaluated the metabolic rate and rest (REE) and oxidation of substrates (lipids and carbohydrates)
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Title
Changes in total cholesterol and lipid fractions
Description
Collected in EDTA tubes, were centrifuged.
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Title
Changes in plasma taurine concentration
Description
Collected in EDTA tubes, were centrifuged and the plasma taurine concentration was evaluated using HPLC (high performance liquid chromatography).
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Title
Changes in plasma irisin concentration
Description
Collected in EDTA tubes, were centrifuged and the plasma irisin concentration was evaluated using Multiplex - Kit Human Myokine Magnetic Bead Panel.
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Title
Changes Food intake
Description
Food registry of 3 days. The quantification of the daily intake of nutrients will still be made using sofware.
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Title
Changes in determination of lactate
Description
Blood samples were collected by manual puncture of the earlobe in previously calibrated and heparinized capillary tubes, stored in eppendorf with sodium fluoride. Analyzed by electrochemical lactate analyser.
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Title
Changes Physical Performance
Description
Maximum effort test, according to Wilder, Brennan e Schotte (1993).
Time Frame
Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
This study included women with obesity grade I (BMI ≥30 - ≤35Kg/m²), sedentary, with no associated comorbidity, convenience sample.
Exclusion Criteria:
Women classified as overweight, obesity grade II and grade III (morbid), who present comorbidities associated with obesity (pre-diabetes, diabetes, hypertension, dyslipidemia, cardiovascular diseases and diseases of bone metabolism); smokers; who use hormones, sports supplements and / or weight loss medications. Perform some type of nutritional monitoring followed by diet or weight loss guidelines and that have medical impediment to the practice of physical exercise.
Facility Information:
Facility Name
Gabriela Batitucci
City
Ribeirão Preto
State/Province
SP
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Taurine Supplementation and Exercise on Irisin Levels in Obesity
We'll reach out to this number within 24 hrs